Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Adamchak Mark. Officer active across 1 company, notably Bionano Genomics, Inc.. In total, 4 filings have been published. Activity tracked since 15 February 2025. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Adamchak Mark is a declarant linked to Bionano Genomics, Inc. (XNAS) as Principal Accounting Officer. The record shows 4 filings in total, and the sampled recent filings cover the period from 2025-02-19 to 2026-06-03, with a transaction nature indicated as tax withholding and individual amounts of EUR 22.68881421230054, EUR 21.90854023661194, EUR 7.835100349322262, and EUR 2.78483715551199.